Fady Ibraham Malik
Net Worth

Last updated:

What is Fady Ibraham Malik net worth?

The estimated net worth of Dr. Fady Ibraham Malik is at least $37,980,089 as of 10 Dec 2024. He owns shares worth $4,490,787 as insider, has earned $24,505,522 from insider trading and has received compensation worth at least $8,983,780 in Cytokinetics, Incorporated.

What is the salary of Fady Ibraham Malik?

Dr. Fady Ibraham Malik salary is $691,060 per year as Executive Vice President of R&D in Cytokinetics, Incorporated.

How old is Fady Ibraham Malik?

Dr. Fady Ibraham Malik is 61 years old, born in 1964.

What stocks does Fady Ibraham Malik currently own?

As insider, Dr. Fady Ibraham Malik owns shares in one company:

Company Title Shares Price per share Total value
Cytokinetics, Incorporated (CYTK) Executive Vice President of R&D 116,071 $38.69 $4,490,787

What does Cytokinetics, Incorporated do?

Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates include omecamtiv mecarbil, a novel cardiac myosin activator that is in Phase III clinical trial in patients with heart failure; and reldesemtiv, a skeletal muscle troponin activator, which is in Phase III clinical trial to treat amyotrophic lateral sclerosis and spinal muscular atrophy. The company also develops CK-136, a novel cardiac troponin activator that is in Phase I clinical trial; aficamten, a novel cardiac myosin inhibitor, which is in Phase III clinical trial for the treatment of patients with symptomatic obstructive hypertrophic cardiomyopathy; and CK-3772271, a small molecule cardiac myosin inhibitor that is in Phase I clinical trial. Cytokinetics, Incorporated has a strategic alliance with Astellas Pharma Inc. The company was incorporated in 1997 and is headquartered in South San Francisco, California.

CYTK logo
CYTK
Cytokinetics, Incorporated
$38.69

Fady Ibraham Malik insider trading

Cytokinetics, Incorporated

Dr. Fady Ibraham Malik has made 91 insider trades between 2012-2024, according to the Form 4 filled with the SEC.

The largest trade he's ever made was exercising 87,500 units of CYTK stock on 4 Sep 2012. As of 10 Dec 2024 he still owns at least 116,071 units of CYTK stock.

Transaction Date Security Shares Price per share Total value Source
Option
Common Stock 5,300 $7.96 $42,188
Option
Non-Qualified Stock Option (Right to Buy) 5,300 $7.96 $42,188
Sale
Common Stock 2,000 $50.65 $101,300
Sale
Common Stock 5,300 $50.63 $268,339
Sale
Common Stock 2,000 $50.14 $100,280
Sale
Common Stock 5,300 $50.17 $265,901
Option
Common Stock 5,300 $7.96 $42,188
Option
Non-Qualified Stock Option (Right to Buy) 5,300 $7.96 $42,188
Option
Non-Qualified Stock Option (Right to Buy) 5,300 $7.96 $42,188
Sale
Common Stock 5,300 $58.48 $309,944
Sale
Common Stock 1,042 $58.48 $60,936
Option
Common Stock 5,300 $7.96 $42,188
Sale
Common Stock 5,300 $51.9 $275,070
Option
Non-Qualified Stock Option (Right to Buy) 5,300 $7.96 $42,188
Option
Common Stock 5,300 $7.96 $42,188
Sale
Common Stock 2,000 $51.93 $103,860
Sale
Common Stock 2,000 $54.2 $108,400
Option
Non-Qualified Stock Option (Right to Buy) 5,300 $7.96 $42,188
Sale
Common Stock 5,300 $54.18 $287,154
Option
Common Stock 5,300 $7.96 $42,188
Option
Non-Qualified Stock Option (Right to Buy) 5,300 $7.96 $42,188
Sale
Common Stock 7,300 $52.1 $380,330
Option
Common Stock 5,300 $7.96 $42,188
Option
Non-Qualified Stock Option (Right to Buy) 5,300 $7.96 $42,188
Option
Common Stock 5,300 $7.96 $42,188
Sale
Common Stock 5,300 $56.77 $300,881
Sale
Common Stock 2,000 $56.76 $113,520
Option
Common Stock 5,300 $7.96 $42,188
Option
Non-Qualified Stock Option (Right to Buy) 5,300 $7.96 $42,188
Sale
Common Stock 7,384 $57.01 $420,925
Option
Common Stock 5,300 $7.96 $42,188
Option
Non-Qualified Stock Option (Right to Buy) 5,300 $7.96 $42,188
Sale
Common Stock 7,300 $56.25 $410,589
Option
Non-Qualified Stock Option (Right to Buy) 5,300 $7.96 $42,188
Option
Common Stock 5,300 $7.96 $42,188
Sale
Common Stock 2,000 $53.74 $107,480
Sale
Common Stock 5,300 $53.7 $284,610
Option
Common Stock 5,422 $7.96 $43,159
Option
Non-Qualified Stock Option (Right to Buy) 5,422 $7.96 $43,159
Sale
Common Stock 5,422 $53.05 $287,637
Sale
Common Stock 2,366 $53.03 $125,469
Sale
Common Stock 14,186 $65.11 $923,650
Option
Common Stock 14,186 $6.67 $94,621
Option
Incentive Stock Option (Right to Buy) 14,186 $6.67 $94,621
Sale
Common Stock 1,361 $65.11 $88,615
Sale
Common Stock 4,000 $74.32 $297,280
Sale
Common Stock 28,605 $74.31 $2,125,638
Option
Non-Qualified Stock Option (Right to Buy) 28,605 $6.67 $190,795
Option
Common Stock 28,605 $6.67 $190,795
Option
Non-Qualified Stock Option (Right to Buy) 28,604 $6.67 $190,789
Option
Common Stock 28,604 $6.67 $190,789
Sale
Common Stock 32,604 $67.55 $2,202,237
Option
Non-Qualified Stock Option (Right to Buy) 28,605 $6.67 $190,795
Sale
Common Stock 4,000 $79.28 $317,120
Option
Common Stock 28,605 $6.67 $190,795
Sale
Common Stock 28,605 $79.3 $2,268,377
Option
Common Stock 11,678 $7.96 $92,957
Sale
Common Stock 11,678 $86.98 $1,015,752
Option
Incentive Stock Option (Right to Buy) 11,678 $7.96 $92,957
Sale
Common Stock 4,000 $86.99 $347,960
Sale
Common Stock 2,500 $35.4 $88,500
Sale
Common Stock 2,500 $35.89 $89,725
Sale
Common Stock 2,500 $34.86 $87,150
Sale
Common Stock 2,500 $31.7 $79,250
Sale
Common Stock 2,500 $35.37 $88,425
Sale
Common Stock 2,500 $38.07 $95,175
Sale
Common Stock 1,787 $39.5 $70,587
Sale
Common Stock 7,000 $40 $280,000
Option
Common Stock 7,000 $7.96 $55,720
Option
Non-Qualified Stock Option (Right to Buy) 7,000 $7.96 $55,720
Sale
Common Stock 4,000 $34.21 $136,840
Sale
Common Stock 4,000 $39.1 $156,400
Sale
Common Stock 4,000 $43.73 $174,920
Option
Non-Qualified Stock Option (Right to Buy) 7,000 $7.96 $55,720
Option
Common Stock 7,000 $7.96 $55,720
Sale
Common Stock 7,000 $43.74 $306,180
Sale
Common Stock 4,000 $40.47 $161,880
Sale
Common Stock 4,000 $36.28 $145,120
Sale
Common Stock 4,000 $38.04 $152,160
Option
Non-Qualified Stock Option (Right to Buy) 21,513 $9.65 $207,600
Sale
Common Stock 21,513 $47.28 $1,017,135
Option
Common Stock 21,513 $9.65 $207,600
Option
Common Stock 21,500 $9.65 $207,475
Sale
Common Stock 21,500 $51.88 $1,115,420
Option
Non-Qualified Stock Option (Right to Buy) 21,500 $9.65 $207,475
Option
Non-Qualified Stock Option (Right to Buy) 21,500 $9.65 $207,475
Sale
Common Stock 21,500 $43.43 $933,745
Option
Common Stock 21,500 $9.65 $207,475
Option
Common Stock 21,500 $9.65 $207,475
Sale
Common Stock 21,500 $40.62 $873,330
Option
Non-Qualified Stock Option (Right to Buy) 21,500 $9.65 $207,475
Sale
Common Stock 13,987 $37.54 $525,072
Option
Incentive Stock Option (right to buy) 13,987 $9.65 $134,975
Option
Common Stock 13,987 $9.65 $134,975
Option
Non-Qualified Stock Option (right to buy) 23,148 $6 $138,888
Sale
Common Stock 23,148 $42.59 $985,758
Option
Common Stock 23,148 $6 $138,888
Sale
Common Stock 26,852 $37.82 $1,015,462
Option
Common Stock 26,852 $6 $161,112
Option
Incentive Stock Option (right to buy) 26,852 $6 $161,112
Sale
Common Stock 22,739 $36.49 $829,769
Option
Common Stock 6,427 $6.3 $40,490
Option
Non-Qualified Stock Option (right to buy) 12,854 $6.3 $80,980
Option
Common Stock 22,739 $6.3 $143,256
Sale
Common Stock 2,000 $39.56 $79,120
Sale
Common Stock 2,000 $37.73 $75,452
Sale
Common Stock 2,000 $31.43 $62,860
Sale
Common Stock 2,000 $32.6 $65,200
Sale
Common Stock 2,000 N/A N/A
Sale
Common Stock 2,000 N/A N/A
Sale
Common Stock 2,000 $24.42 $48,840
Sale
Common Stock 2,000 $23.39 $46,772
Sale
Common Stock 2,000 $19.9 $39,798
Sale
Common Stock 1,632 $23.34 $38,097
Option
Common Stock 12,500 $14.34 $179,188
Sale
Common Stock 617 $19.25 $11,877
Option
Incentive Stock Option (right to buy) 11,883 $9.42 $111,938
Sale
Common Stock 1,052 $20.13 $21,177
Sale
Common Stock 1,231 $17.15 $21,112
Sale
Common Stock 1,258 $17.45 $21,952
Sale
Common Stock 995 $22.85 $22,736
Sale
Common Stock 599 $21.85 $13,088
Sale
Common Stock 1,587 $26.96 $42,786
Sale
Common Stock 1,500 $9.8 $14,700
Sale
Common Stock 1,500 $9.98 $14,970
Sale
Common Stock 1,500 $11.22 $16,830
Sale
Common Stock 1,500 $13.69 $20,532
Sale
Common Stock 1,500 $13.52 $20,280
Sale
Common Stock 1,500 $11.26 $16,890
Sale
Common Stock 1,500 $10.31 $15,463
Sale
Common Stock 1,500 $8.29 $12,431
Sale
Common Stock 1,500 $8.31 $12,465
Sale
Common Stock 1,500 $5.98 $8,970
Sale
Common Stock 1,500 $7.28 $10,920
Sale
Common Stock 1,500 $7.31 $10,965
Sale
Common Stock 1,500 $7.38 $11,070
Sale
Common Stock 1,500 $6.68 $10,020
Sale
Common Stock 1,500 $9.14 $13,710
Sale
Common Stock 1,500 $8 $12,000
Sale
Common Stock 1,500 $6.85 $10,275
Sale
Common Stock 1,500 $9.05 $13,575
Sale
Common Stock 3,000 $8.95 $26,850
Option
Common Stock 6,666 $11.1 $73,993
Option
Incentive Stock Option (right to buy) 5,278 $11.1 $58,586
Option
Non-Qualified Stock Option (right to buy) 694 $11.1 $7,703
Sale
Common Stock 7,321 $13.51 $98,936
Sale
Common Stock 1,326 $12.52 $16,600
Sale
Common Stock 4,307 $12.31 $53,032
Sale
Common Stock 21,630 $6.75 $145,916
Option
Common Stock 14,583 N/A N/A
Option
Restricted Stock Units 14,583 N/A N/A
Option
Common Stock 87,500 $1.05 $91,875
Option
Restricted Stock Units 87,500 $1.05 $91,875

Cytokinetics, Incorporated key executives

Cytokinetics, Incorporated executives and other stock owners filed with the SEC: